Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-06-03 Sale |
2024-06-05 4:18 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $15.22 | $152,185 | 62,485 (Direct) |
View |
2024-05-20 Sale |
2024-05-22 4:20 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $15.39 | $769,500 | 46,000 (Direct) |
View |
2024-05-20 Sale |
2024-05-22 4:17 pm |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
42,350 | $15.43 | $653,529 | 27,000 (Direct) |
View |
2024-05-20 Sale |
2024-05-22 4:15 pm |
Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC |
8,599 | $15.04 | $129,327 | 28,399 (Direct) |
View |
2024-05-01 Sale |
2024-05-03 4:24 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $11.37 | $113,653 | 72,485 (Direct) |
View |
2024-04-17 Sale |
2024-04-18 4:16 pm |
Stoke Therapeutics Inc. | STOK | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner |
3,600,000 | $11.6 | $41,760,000 | 10,843,681 (Indirect) |
View |
2024-04-01 Sale |
2024-04-03 4:21 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
9,426 | $13.23 | $124,684 | 82,485 (Direct) |
View |
2024-04-01 Sale |
2024-04-03 4:19 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
61,329 | $13.23 | $811,212 | 96,000 (Direct) |
View |
2024-03-28 Sale |
2024-04-01 4:14 pm |
Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC |
5,126 | $13.2 | $67,668 | 2,598 (Direct) |
View |
2024-03-19 Sale |
2024-03-19 8:36 pm |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
4,116 | $6.0986 | $25,102 | 60,046 (Direct) |
View |
2024-03-19 Sale |
2024-03-19 8:34 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
4,116 | $6.0986 | $25,102 | 50,769 (Direct) |
View |
2024-03-19 Sale |
2024-03-19 8:31 pm |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
4,116 | $6.0986 | $25,102 | 50,629 (Direct) |
View |
2024-03-19 Sale |
2024-03-19 8:30 pm |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
11,150 | $6.0986 | $67,999 | 175,850 (Direct) |
View |
2024-03-19 Sale |
2024-03-19 8:29 pm |
Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC |
2,349 | $6.0986 | $14,326 | 30,149 (Direct) |
View |
2024-03-01 Sale |
2024-03-05 4:21 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $7.7469 | $77,469 | 82,927 (Direct) |
View |
2024-02-01 Sale |
2024-02-05 4:32 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $4.7991 | $47,991 | 6,981 (Direct) |
View |
2024-01-02 Sale |
2024-01-04 4:38 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
10,000 | $5.7352 | $57,352 | 16,981 (Direct) |
View |
2023-07-03 Sale |
2023-07-06 5:20 pm |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
15,000 | $10.6 | $158,973 | 25,895 (Direct) |
View |
2023-06-21 Sale |
2023-06-23 4:45 pm |
Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec |
1,948 | $13.48 | $26,252 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-06-05 Option Award |
2024-06-07 4:27 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:23 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | SMITH IAN F Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:21 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | Menzel Garry E Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:19 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:18 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-06-05 Option Award |
2024-06-07 4:16 pm |
N/A 2034-06-04 |
Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director |
7,639 | $0 | 7,639 (Direct) |
View |
2024-06-03 Exercise |
2024-06-05 4:18 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $0 | 62,485 (Direct) |
View |
2024-06-03 Exercise |
2024-06-05 4:18 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $0.6 | 62,485 (Direct) |
View |
2024-05-20 Exercise |
2024-05-22 4:20 pm |
N/A 2026-02-11 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0 | 46,000 (Direct) |
View |
2024-05-20 Exercise |
2024-05-22 4:20 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0.4 | 46,000 (Direct) |
View |
2024-05-20 Exercise |
2024-05-22 4:15 pm |
N/A 2032-12-06 |
Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC |
8,599 | $0 | 28,399 (Direct) |
View |
2024-05-20 Exercise |
2024-05-22 4:15 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC |
8,599 | $7.07 | 28,399 (Direct) |
View |
2024-05-15 Option Award |
2024-05-17 4:14 pm |
N/A 2034-05-14 |
Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer |
396,200 | $0 | 396,200 (Direct) |
View |
2024-05-01 Exercise |
2024-05-03 4:24 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $0 | 72,485 (Direct) |
View |
2024-05-01 Exercise |
2024-05-03 4:24 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
10,000 | $0.6 | 72,485 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 4:21 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
442 | $0 | 82,485 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 4:21 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
442 | $0.6 | 82,485 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 4:19 pm |
N/A 2026-02-11 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0 | 96,000 (Direct) |
View |
2024-04-01 Exercise |
2024-04-03 4:19 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
50,000 | $0.4 | 96,000 (Direct) |
View |
2024-03-15 Exercise |
2024-03-19 8:36 pm |
N/A 2027-03-15 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
13,100 | $0 | 60,046 (Direct) |
View |
2024-03-15 Exercise |
2024-03-19 8:34 pm |
N/A 2027-03-15 |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
13,100 | $0 | 50,769 (Direct) |
View |
2024-03-15 Exercise |
2024-03-19 8:31 pm |
N/A 2027-03-15 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
13,100 | $0 | 50,629 (Direct) |
View |
2024-03-15 Exercise |
2024-03-19 8:30 pm |
N/A 2027-03-15 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
35,500 | $0 | 175,850 (Direct) |
View |
2024-03-15 Exercise |
2024-03-19 8:29 pm |
N/A 2027-03-15 |
Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC |
7,475 | $0 | 30,149 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:21 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
5,504 | $0 | 82,927 (Direct) |
View |
2024-03-01 Exercise |
2024-03-05 4:21 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER |
5,504 | $0.6 | 82,927 (Direct) |
View |
2024-02-13 Exercise |
2024-02-15 4:17 pm |
N/A 2028-12-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
31,739 | $0 | 31,739 (Direct) |
View |
2024-02-13 Exercise |
2024-02-15 4:17 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
31,739 | $2.19 | 31,739 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 4:20 pm |
N/A 2025-12-01 |
Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO |
60,773 | $0 | 60,773 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 4:18 pm |
N/A 2025-12-01 |
Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer |
60,773 | $0 | 60,773 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 4:17 pm |
N/A 2025-12-01 |
Stoke Therapeutics Inc. | STOK | Nash Huw M. COO & CBO |
8,463 | $0 | 8,463 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 4:15 pm |
N/A 2025-12-01 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
25,908 | $0 | 25,908 (Direct) |
View |
2023-12-01 Option Award |
2023-12-05 4:09 pm |
N/A 2025-12-01 |
Stoke Therapeutics Inc. | STOK | Allan Jonathan General Counsel & Corp Sec |
46,284 | $0 | 46,284 (Direct) |
View |
2023-09-19 Option Award |
2023-09-20 4:48 pm |
N/A 2033-09-18 |
Stoke Therapeutics Inc. | STOK | SMITH IAN F Director |
96,340 | $0 | 96,340 (Direct) |
View |
2023-03-27 Exercise |
2023-09-08 4:15 pm |
N/A 2028-04-02 |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
20,000 | $0 | 647,801 (Direct) |
View |
2023-03-27 Exercise |
2023-09-08 4:15 pm |
N/A N/A |
Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO |
20,000 | $0.6 | 647,801 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 6:26 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director |
19,441 | $0 | 19,441 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 6:26 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Smith Julie Director |
19,441 | $0 | 19,441 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 6:25 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | Menzel Garry E Director |
19,441 | $0 | 19,441 (Direct) |
View |
2023-06-13 Option Award |
2023-06-15 6:24 pm |
N/A 2033-06-12 |
Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director |
19,441 | $0 | 19,441 (Direct) |
View |